These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 790807)

  • 21. Naftidrofuryl in chronic arterial disease. Results of a controlled multicenter study.
    Trübestein G; Böhme H; Heidrich H; Heinrich F; Hirche H; Maass U; Mörl H; Rudofsky G
    Angiology; 1984 Nov; 35(11):701-8. PubMed ID: 6388425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single blind study of naftidrofuryl in the treatment of peripheral vascular disorders in general practice.
    Clyne MB; Lask A
    Br J Clin Pract; 1978 Jun; 32(6):169-71. PubMed ID: 354670
    [No Abstract]   [Full Text] [Related]  

  • 23. tcpO2, arterial blood flow and lactate/pyruvate modifications induced by a single dose of naftidrofuryl IV during stage III lower-limb arteriopathies.
    Pointel JP; Thomas C; Mosnier M; Percebois G; Debry G
    Angiology; 1986 Sep; 37(9):647-53. PubMed ID: 3767072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of naftidrofuryl on creatinine serum concentration and on PAH/inulin clearance in peripheral arterial occlusive diseases].
    Heidrich VH; Baethke R; Beyer KH
    Arzneimittelforschung; 1975 Mar; 25(3):429-31. PubMed ID: 1174049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The usefulness of naftidrofuryl in severe peripheral ischaemia--a symptomatic assessment using linear analogue scales.
    Meehan SE; Preece PE; Walker WF
    Angiology; 1982 Oct; 33(10):625-34. PubMed ID: 6751162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind evaluation of naftidrofuryl in treating elderly confused hospitalised patients.
    Cox JR
    Gerontol Clin (Basel); 1975; 17(3):160-7. PubMed ID: 1102394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immediate effects of naftidrofuryl on the human electrocochleogram in Ménière's disorder.
    Gibson WP; Ramsden RT; Moffat DA
    J Laryngol Otol; 1977 Aug; 91(8):679-96. PubMed ID: 894121
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy of sudden deafness--naftidrofuryl (Dusodril) and pentoxifylline (Trental) compared].
    Laskawi R; Schrader B; Schröder M; Poser R; von der Brelie R
    Laryngol Rhinol Otol (Stuttg); 1987 May; 66(5):242-5. PubMed ID: 3302568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preliminary results of a long-term double-blind study of naftidrofuryl and a placebo in patients with moderate Alzheimer-type senile dementia].
    Cucinotta D; Dall'Asta D; Benaglia F; Barbagallo M; Butturini L; Pioli G; Salomone M
    G Clin Med; 1985; 66(11-12):467-76. PubMed ID: 3835091
    [No Abstract]   [Full Text] [Related]  

  • 30. The therapeutic uses of naftidrofuryl (Praxilene)--cerebrovascular disease.
    Judge TG
    Scott Med J; 1978 Jan; 23(1):43-4. PubMed ID: 635539
    [No Abstract]   [Full Text] [Related]  

  • 31. [Naftidrofuryl in stages III and IV of peripheral arterial occlusive disease].
    Horsch S
    Vasa Suppl; 1988; 24():38-43. PubMed ID: 3212602
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of naftidrofuryl on the time course of the regional cerebral blood flow in acute ischemic stroke.
    Kobayashi S; Yamaguchi S; Katsube T; Okada K; Kitani M; Murao M; Tsunematsu T
    Arzneimittelforschung; 1984; 34(11):1580-3. PubMed ID: 6543134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naftidrofuryl for intermittent claudication: a double-blind controlled trial.
    Ruckley CV; Callam MJ; Ferrington CM; Prescott RJ
    Br Med J; 1978 Mar; 1(6113):622. PubMed ID: 343869
    [No Abstract]   [Full Text] [Related]  

  • 34. [Naftidrofuryl in the treatment of obstructive arterial diseases of the lower extremities].
    Ciammaichella A; Solitro A; Arcuri P
    Minerva Cardioangiol; 1975 Oct; 23(10):607-21. PubMed ID: 1232566
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of naftidrofuryl (Praxilene) on intermittent claudication.
    Waters KJ; Craxford AD; Chamberlain J
    Br J Surg; 1980 May; 67(5):349-51. PubMed ID: 6992910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of intravenous naftidrofuryl on the microcirculation of patients in stages III and IV of arterial occlusive disease].
    Abendroth D; Sunder-Plassmann L
    Vasa Suppl; 1988; 24():33-7. PubMed ID: 3212601
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical ophthalmodynamographic results of the treatment of cerebral circulation disorders with O-(beta-hydroxyethyl)-rutoside].
    Tzavellas O
    Arzneimittelforschung; 1970 Sep; 20(9):1187-90. PubMed ID: 5536794
    [No Abstract]   [Full Text] [Related]  

  • 38. [Naftidrofuryl in the treatment of simple diabetic retinopathy. A double-blind study].
    Klein M; Hirche H
    Klin Monbl Augenheilkd; 1985 Sep; 187(3):195-201. PubMed ID: 3906248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of intravenous naftidrofuryl on transcutaneous oxygen pressure in severe peripheral vascular disease.
    Taggart I; Wishart GC; Cuschieri RJ; MacBain GC
    Angiology; 1989 Oct; 40(10):895-8. PubMed ID: 2802260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of oxygen inhalation and intravenous naftidrofuryl on the transcutaneous partial oxygen pressure in ischaemic lower limbs.
    Mustapha NM; Jain SK; Dudley P; Redhead RG
    Prosthet Orthot Int; 1984 Dec; 8(3):135-8. PubMed ID: 6522254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.